Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States

Open Forum Infectious Diseases

Volumn 1, Issue 2, 2014, Pages

  Suaya, Jose A ^a   Chen, Shih Yin ^b   Li, Qian ^b   Burstin, Stuart J ^a   Levin, Myron J ^c  

^a GLAXOSMITHKLINE   (United States)

^b EVIDERA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Diabetes; Herpes zoster; Incidence; Post herpetic pain; Risk

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMIZED PATIENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PERSISTENT POST ZOSTER PAIN; PERSISTENT VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

EID: 84961274408     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu049     Document Type: Article

References (44)

1. Levin MJ. Zoster Vaccines. In Plotkin S, Orenstein W, Offitt P, eds. Vaccines. 6th ed. Saunders Elsevier, 2012.
2. Ma L, White RR, Narayanan S, et al. Economic burden of herpes zoster among skilled nursing facility residents in the United States. J Am Med Dir Assoc 2012; 13:54-9.
3. White RR, Lenhart G, Singhal PK, et al. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 2009; 27:781-92.
4. Drolet M, Levin MJ, Schmader KE, et al. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine 2012; 30:2047-50.
5. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82:1341-9.
6. Schmader KE, Johnson GR, Saddier P, et al. Effect of a zoster vaccine on herpes zoster-related interference with functional status and healthrelated quality-of-life measures in older adults. J Am Geriatr Soc 2010; 58:1634-41.
7. Mahamud A, Marin M, Nickell SP, et al. Herpes zoster-related deaths in the United States: validity of death certificates and mortality rates, 1979-2007. Clin Infect Dis 2012; 55:960-6.
8. Weinberg A, Lazar AA, Zerbe GO, et al. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis 2010; 201:1024-30.
9. Reilly ML, Schillie SF, Smith E, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol 2012; 6:858-66.
10. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.MMWR RecommRep 2010; 59(RR-8):1-62.
11. Casey JI, Heeter BJ, Klyshevich KA. Impaired response of lymphocytes of diabetic subjects to antigen of Staphylococcus aureus. J Infect Dis 1977; 136:495-501.
12. Kumar NP, Sridhar R, Banurekha VV, et al. Expansion of pathogenspecific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis 2013; 208:739-48.
13. Plouffe JF, Silva J Jr, Fekety R, et al. Cell-mediated immunity in diabetes mellitus. Infect Immun 1978; 21:425-9.
14. Heymann AD, Chodick G, Karpati T, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36:226-30.
15. Hata A, Kuniyoshi M, Ohkusa Y. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 2011; 39:537-44.
16. Jih JS, Chen YJ, Lin MW, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol 2009; 89:612-6.
17. Brown GR. Herpes zoster: correlation of age, sex, distribution, neuralgia, and associated disorders. South Med J 1976; 69:576-8.
18. McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis 2009; 48:1364-71.
19. Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 61:310-6.
20. Center of Disease and Control. Advisory Committee on Immunization Practices. Prevention of Herpes Zoster. Available at: http://www.cdc. gov/mmwr/preview/mmwrhtml/rr5705a1.htm?s_cid=rr5705a1_e. Accessed 19 July 2012.
21. US Census Bureau. Available at: http://www.census.gov/. Accessed 2 April 2013.
22. National Health and Nutrition Examination Survey. Available at: http:// www.cdc.gov/nchs/nhanes.htm. Accessed 2 July 2013.
23. Langan SM, Smeeth L, Margolis DJ, et al. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 2013; 10:e1001420.
24. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84.
25. Tseng HF, Smith N, Harpaz R, et al. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 2011; 305:160-6.
26. Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol 2011; 174:1054-61.
27. Aldaz P, Diaz JA, Loayssa JR, et al. Herpes zoster incidence in diabetic patients. An Sist Sanit Navar 2013; 36:57-62.
28. Joesoef RM, Harpaz R, Leung J, et al. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc 2012; 87:961-7.
29. Weitzman D, Shavit O, Stein M, et al. A population based study of the epidemiology of Herpes Zoster and its complications. J Infect 2013; 67:463-9.
30. Chen HH, Chen YM, Chen TJ, et al. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (Sao Paulo) 2011; 66:1177-82.
31. Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20:748-53.
32. Leung J, Harpaz R, Molinari NA, et al. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011; 52:332-40.
33. Smitten AL, Choi HK, Hochberg MC, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007; 57:1431-8.
34. Chapman RS, Cross KW, Fleming DM. The incidence of shingles and its implications for vaccination policy. Vaccine 2003; 21:2541-7.
35. Fleming DM, Cross KW, Cobb WA, et al. Gender difference in the incidence of shingles. Epidemiol Infect 2004; 132:1-5.
36. Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137:38-47.
37. Opstelten W, Van Essen GA, Schellevis F, et al. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006; 16:692-5.
38. Russell ML, Schopflocher DP, Svenson L, et al. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007; 135: 908-13.
39. Toyama N, Shiraki K, Society of the Miyazaki Prefecture D. Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol 2009; 81:2053-8.
40. Zhang J, Xie F, Delzell E, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 2012; 308:43-9.
41. Okamoto S, Hata A, Sadaoka K, et al. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis 2009; 200:1606-10.
42. Rhodes ET, Laffel LM, Gonzalez TV, et al. Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Diabetes Care 2007; 30:141-3.
43. Joesoef MR, Leung J, Harpaz R, et al. Potential coding error of herpes zoster (HZ) vaccination and HZ diagnosis in administrative data. Vaccine 2011; 29:2008-9.
44. Lu PJ, Euler GL, Jumaan AO, et al. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009; 27:882-7.